| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 77.3 | 271.2 | 361.5 | 443.1 | 531.1 |
| Age-adjusted comparative prevalence of diabetes, % | - | 9.6 | 8.8 | 10.1 | 10.8 |
| People with undiagnosed diabetes, in 1,000s | - | - | 134.9 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 37.3 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 172.8 | 424.1 | 491.3 | 554.2 |
| Age-adjusted comparative prevalence of IGT, % | - | 5.8 | 10.8 | 11.4 | 11.7 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 492.7 | 578.9 | 656.1 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 9.9 | 10.3 | 10.5 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 1,707.0 | 3,663.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 2.6 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.0 | - | 0.0 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.0 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 0.2 | - | 0.2 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 0.3 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 1,044.8 | 1,206.5 | 1,276.0 |
| Total diabetes-related health expenditure, ID million | - | - | 1,535.1 | 1,772.6 | 1,874.8 |
| Diabetes-related health expenditure per person, USD | - | 924.0 | 2,890.0 | 3,337.1 | 3,529.5 |
| Diabetes-related health expenditure per person, ID | - | - | 4,246.1 | 4,903.0 | 5,185.6 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 2,286.0 | 3,075.6 | 3,603.3 | 3,936.9 | 4,186.3 |
| Population of children (0-14 y), in 1,000s | 1,356.0 | - | 1,057.5 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 1,417.3 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||